Amneal Pharmaceuticals Investor Relations Material
Latest events
Q1 2025
Amneal Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Amneal Pharmaceuticals Inc
Access all reports
Amneal Pharmaceuticals, Inc. is a pharmaceutical company engaged in the development, manufacturing, and distribution of generic and specialty pharmaceutical products. The company offers a wide range of dosage forms, including oral solids, injectables, and topicals, addressing therapeutic areas such as central nervous system disorders, oncology, and cardiovascular conditions. The company is headquartered in Bridgewater, New Jersey, and its shares are listed on the NYSE.
Key slides for Amneal Pharmaceuticals Inc
Q3 2024
Amneal Pharmaceuticals Inc
Q1 2025
Amneal Pharmaceuticals Inc
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
AMRX
Country
🇺🇸 United States